gence because the treatment
option now has its own CPT
code, the proprietary device
used to perform the procedure
has undergone design improve-
ments and longer-term outcomes
data show a persistence of anti-
reflux effect.
• Radiofrequency ablation. A
balloon catheter device is intro-
duced through the mouth to
deliver low levels of radiofre-
quency energy to multiple loca-
tions at the lower esophageal
sphincter, where the energy
changes the tissue's mechanical
properties through shrinking and
scarring, which results in less
reflux. However, according to
Dr. Kahrilas, there is no signifi-
cant clinical evidence to show
the device achieves that goal.
• Ultrasonic surgical endo-
scopic stapling. Surgeons
employ a flexible endoscopic
stapling device to perform a
transoral partial fundoplication.
The device is inserted into the
stomach, where it's retroflexed
before surgeons fire staples into
A P R I L 2 0 1 8 • O U T PA T I E N TS U R G E R Y. N E T • 9 9
Janice
GERD su erer for 4 years
The TIF® procedure with the EsophyX® device is an
incisionless procedure to control typical and atypical
GERD symptoms. In the past 10 years, 4 randomized
controlled trials and more than 70 peer-reviewed
papers have documented consistent outcomes
in over 1,200 unique study patients. So help your
patients today with the TIF® procedure. And help
Janice regain what was lost.
www.EndoGastricSolutions.com
The TIF® procedure is designed to treat GERD symptoms with the EsophyX®
technology – a cleared device. Results may vary; visit GERDHelp.com for clin-
ical data. EndoGastric Solutions, Inc. is the manufacturer and owner of these
trademarks: TIF, EsophyX and SerosaFuse.
©2017 All rights reserved. NP02456-01D
GERD has taken a lot
from your patients.
Help Janice
re-claim herself.
